Human gene therapy - JoVE Visualize

Showing results (2951-2960 of 4,130) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|June 13, 2018

Clinical Evaluations of Toxicity and Efficacy of Nanoparticle-Mediated Gene TherapyXiao Liang, Li Liu, Yu-Quan Wei, et al.

Human Gene Therapy|June 14, 2018

HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer CellsChi Chi, Min Mao, Zongji Shen, et al.

Human Gene Therapy|September 29, 2012

Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosaLaura Fernández-Sánchez, Pedro Lax, Carolina Isiegas, et al.

Human Gene Therapy|February 24, 2015

Humoral and cell-mediated immune response, and growth factor synthesis after direct intraarticular injection of rAAV2-IGF-I and rAAV5-IGF-I in the equine middle carpal jointKyla Ortved, Bettina Wagner, Roberto Calcedo, et al.

Human Gene Therapy|February 4, 1998

Lentiviral vectors for gene therapy of cystic fibrosisM J Goldman, P S Lee, J S Yang, et al.

Human Gene Therapy|February 11, 1998

Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cellsH Namba, M Tagawa, Y Iwadate, et al.

Human Gene Therapy|February 11, 1998

Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectorsM Hildinger, B Fehse, S Hegewisch-Becker, et al.

Human Gene Therapy|February 11, 1998

Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genesD Jung, E Jaeger, S Cayeux, et al.

Human Gene Therapy|February 7, 1998

Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectorsM López-Lastra, C Gabus, J L Darlix

Human Gene Therapy|February 24, 1998

High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocolM Movassagh, C Desmyter, C Baillou, et al.

Pageof 413

Showing results (2951-2960 of 4,130) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|June 13, 2018

Clinical Evaluations of Toxicity and Efficacy of Nanoparticle-Mediated Gene TherapyXiao Liang, Li Liu, Yu-Quan Wei, et al.

Human Gene Therapy|June 14, 2018

HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer CellsChi Chi, Min Mao, Zongji Shen, et al.

Human Gene Therapy|September 29, 2012

Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosaLaura Fernández-Sánchez, Pedro Lax, Carolina Isiegas, et al.

Human Gene Therapy|February 24, 2015

Humoral and cell-mediated immune response, and growth factor synthesis after direct intraarticular injection of rAAV2-IGF-I and rAAV5-IGF-I in the equine middle carpal jointKyla Ortved, Bettina Wagner, Roberto Calcedo, et al.

Human Gene Therapy|February 4, 1998

Lentiviral vectors for gene therapy of cystic fibrosisM J Goldman, P S Lee, J S Yang, et al.

Human Gene Therapy|February 11, 1998

Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cellsH Namba, M Tagawa, Y Iwadate, et al.

Human Gene Therapy|February 11, 1998

Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectorsM Hildinger, B Fehse, S Hegewisch-Becker, et al.

Human Gene Therapy|February 11, 1998

Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genesD Jung, E Jaeger, S Cayeux, et al.

Human Gene Therapy|February 7, 1998

Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectorsM López-Lastra, C Gabus, J L Darlix

Human Gene Therapy|February 24, 1998

High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocolM Movassagh, C Desmyter, C Baillou, et al.

Pageof 413